The reduction in miRNA-192-5p expression promotes IRAK1 expression in endometrial cancer cells and activates NF-κβ signaling, inhibiting apoptosis and promoting tumor development (Wang et al., 2022b). The gene discussed is IRAK1; the disease is neoplasm.